Results 201 to 210 of about 1,046,192 (353)

Wellness in the invisible workforce: a pilot well-being study in black, indigenous, and people of color (BIPOC) women faculty in the pharmacy and pharmaceutical sciences. [PDF]

BMC Med Educ
Harris SC, Loop MS, Tanni KA, Jackson KD, White CY.   +4 more
europepmc   +1 more source

An evaluation of learning environment conditions required to reduce student stress: A case study of students from the school of pharmaceutical sciences in collaboration with Otgontenger University [PDF]

Ulziimaa Doyod, Anudari Chinbat, Ulziikhishig Tsedendamb   +2 more
openalex   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Text summarization for pharmaceutical sciences using hierarchical clustering with a weighted evaluation methodology. [PDF]

Sci Rep
Dalal A, Ranjan S, Bopaiah Y, Chembachere D, Steiger N, Burns C, Daswani V.   +6 more
europepmc   +1 more source

A Cost-Benefit Analysis of Teaching and Learning Technology in a Faculty of Pharmaceutical Sciences. [PDF]

Am J Pharm Educ, 2019
Harrison M, Quisias J, Frew EJ, Albon SP.   +3 more
europepmc   +1 more source

Virtual or In‐Person: Does It Matter? Comparing Pain, Function, Quality of Life, Self‐Efficacy, and Physical Function Outcomes of Virtual, Hybrid, and In‐Person Education and Exercise Program Participants

Arthritis Care &Research, EarlyView.
Objective This study aimed to determine if program format (in‐person, virtual, or hybrid) results in differences in 3‐month outcomes of pain, function, quality of life, self‐efficacy, and chair stands in a hip/knee osteoarthritis‐management program. Methods A secondary analysis of the Good Life with osteoArthritis in Denmark (GLA:D) Canada database was
Jill Van Damme, Vanina Dal Bello‐Haas, Ayse Kuspinar, Patricia Strachan, Michael Zywiel, James Young, Rhona McGlasson, Lisa C. Carlesso   +7 more
wiley   +1 more source

Harmonizing Innovations: An In-Depth Comparative Review on the Formulation, Applications, and Future Perspectives of Aerogels and Hydrogels in Pharmaceutical Sciences. [PDF]

Gels
Alaghawani NA, Alkhatib H, Elmancy L, Daou A.   +3 more
europepmc   +1 more source

Hip Morphology–Based Osteoarthritis Risk Prediction Models: Development and External Validation Using Individual Participant Data From the World COACH Consortium

Arthritis Care &Research, EarlyView.
Objective This study aims to develop hip morphology‐based radiographic hip osteoarthritis (RHOA) risk prediction models and investigates the added predictive value of hip morphology measurements and the generalizability to different populations. Methods We combined data from nine prospective cohort studies participating in the Worldwide Collaboration ...
Myrthe A. van den Berg, Fleur Boel, Michiel M. A. van Buuren, Noortje S. Riedstra, Jinchi Tang, Harbeer Ahedi, Nigel K. Arden, Sita M. A. Bierma‐Zeinstra, Cindy G. Boer, Flavia M. Cicuttini, Timothy F. Cootes, David T. Felson, Willem Paul Gielis, Joshua Heerey, Graeme Jones, Stefan Kluzek, Nancy E. Lane, Claudia Lindner, Joyce B. J. van Meurs, Andrea Mosler, Amanda E. Nelson, Michael C. Nevitt, Edwin H. Oei, Jos Runhaar, Harrie Weinans, Jesse H. Krijthe, Rintje Agricola   +26 more
wiley   +1 more source

Pharmaceutical sciences scenario in CNPq research fellowship

Brazilian Journal of Pharmaceutical Sciences, 2013
Silvia Stanisçuaski Guterres, João Luis Callegari Lopes, Eliezer J. Barreiro, João Carlos Palazzo de Mello   +3 more
doaj   +1 more source

Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review. [PDF]

Iran J Pharm Res
Mottaghi-Dastjerdi N, Soltany-Rezaee-Rad M.   +1 more
europepmc   +1 more source